KOL Insight Archives | Page 7 of 16 | Report Store

Multiple Sclerosis (MS) KOL Interview – UK, London

In this interview, a UK-based key opinion leader (KOL) discusses typical prescribing habits for disease-modifying therapies (DMTs) in MS. This includes first-generation DMTs and the newer, more potent entrants like Ocrevus, as well as late-stage pipeline DMTs.

KOL Insight

Multiple Sclerosis (MS) KOL Interview – UK, London

Multiple Sclerosis (MS) KOL Interview – UK, Southwest

Multiple Sclerosis (MS) KOL Interview – US, Midwest

2019 ASH Pulse Survey

Type 1 Diabetes KOL Interview – UK

Type 1 Diabetes KOL Interview – US, Midwest

Human Papillomavirus (HPV) KOL Interview – Italy

Human Papillomavirus (HPV) KOL Interview – US, Midwest

Triple-Negative Breast Cancer KOL Interview – UK

Triple-Negative Breast Cancer KOL Interview – US

Rheumatoid Arthritis Payer Interview – Pennsylvania, US

Rheumatoid Arthritis Payer Interview – UK

Rheumatoid Arthritis KOL Interview – California, US

Rheumatoid Arthritis KOL Interview – UK

Rheumatoid Arthritis KOL Interview – New Jersey, US